The Food and Drug Administration … The new pill, Foundayo, is taken once a day and will compete with the pill form of Wegovy, made by Novo Nordisk, which was approved by the FDA in December ….
Hey folks, gather ‘round because we need to talk about a little something called Foundayo. No, it’s not the name of the latest trendy coffee shop or a new dance move; it’s Eli Lilly’s new oral GLP-1 medication that’s taking the weight-loss world by storm. According to the big cheese over at Eli Lilly, approximately one-third of new patients trying out this pill are hopping on the Foundayo train. And let’s be honest, who wouldn’t want to jump on a train that promises a little extra help in shedding those stubborn pounds?
Now, you might be wondering, what in the world is GLP-1? It sounds like a robot from a sci-fi movie, but in reality, it’s a type of medication that helps manage weight by mimicking a hormone that makes you feel full. So, if you’re tired of the endless cycle of diets that leave you feeling hangry and deprived, Foundayo might just be your new best friend.
Eli Lilly’s CEO recently spilled the beans on CNBC about how they’re seeing some serious growth in the pill market. You’d think they were selling the latest iPhone with the way they’re ramping up production. They’re not just playing around; they’re in it to win it. Their manufacturing capabilities are set to expand significantly, with a shiny new $6.5 billion facility breaking ground in Houston, Texas. Yes, you heard that right—billion with a ‘B’. The facility is expected to be operational by 2030, which feels like an eternity, but hey, good things come to those who wait, right?
And it’s not just about the numbers; Foundayo is making a name for itself in a competitive market. With more people jumping on the GLP-1 bandwagon, Eli Lilly is positioning itself to grab a hefty slice of the pie—err, pill market. They’re not just sitting back and twiddling their thumbs while competitors like Novo Nordisk and others are nipping at their heels. No, they’re all about that week-over-week growth. It’s almost like they’re in a race, and they’re determined to cross the finish line first.
But let’s be real for a second—while the idea of a magic pill that helps you lose weight sounds fantastic, it’s essential to remember that it’s not a one-size-fits-all solution. As with any medication, it’s crucial to consult with your healthcare provider before diving into the world of GLP-1s. You don’t want to end up in a situation where you’re popping pills without understanding how they work or if they’re suitable for you.
In conclusion, Eli Lilly’s Foundayo is making headlines, and for a good reason. With a growing number of patients opting for this oral medication, and the company investing big bucks into its production capabilities, it seems that Foundayo is here to stay. So, whether you’re considering trying it out or just curious about the latest developments in the weight loss industry, it’s safe to say that Foundayo is certainly a name to remember. Who knows? It might just be the ticket to finally fitting into those jeans you’ve been eyeing since 2010. Happy weight loss, everyone!
Inspired by: “Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ram…” (r/Business)